Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Refractive Surgery/Vision Correction > Contact Lenses > New Acuvue Oasys multifocal contact lens for patients with presbyopia available in the US
  • Contact Lenses

New Acuvue Oasys multifocal contact lens for patients with presbyopia available in the US

Ophthalmology 360
New Acuvue Oasys multifocal contact lens for patients with presbyopia available in the US

Acuvue Oasys (Johnson & Johnson Vision) multifocal contact lenses with pupil optimized design for patients with presbyopia are now available in the United States and Canada, according to a company press release.

“This Acuvue Oasys multifocal contact lens brings a long-awaited solution to patients with presbyopia who have been looking for continuous, clear and comfortable vision at all distances,” said Xiao-Yu Song, MD, PhD, Global Head of Research & Development, Johnson & Johnson Vision in the press release.

Read the full press release here.

Share

Related Content

  • Cataract

Spotlight on TECNIS Odyssey™

  • Cataract

IOL exchange shows highest success for dissatisfaction after presbyopia-correcting lens surgery

  • Conference Roundup

OmniVu modular shape-changing IOL offers stable refraction and sustained improvement in near vision

  • Conference Roundup

How depth of field IOL technologies can provide tolerance to refractive error

  • Contact Lenses

Blue-violet filtering contact lenses improve contrast sensitivity in low light and glare

  • Refractive Surgery/Vision Correction

First-in-human study underway for non-invasive vision correction technology

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon